This book is unique to me in that while I wholly support the general conclusion and theme of the book, I find that I am at odds with essentially everyThis book is unique to me in that while I wholly support the general conclusion and theme of the book, I find that I am at odds with essentially every argument made by the author. I agree with the ends, but find the means to it objectionable. The examples and arguments in the book are at best misinformed, and at worst wrong and misleading. The conclusion that American patients should have access to live saving medications before approval by the FDA is worthwhile and noble, but such a stronger case can be made for it. The author misses this opportunity to concisely defend why early access is appropriate....more